Zoetis ZTS
NYSE ZTS
$77.73 +2.71 (+3.61%)
At close: Aug 21, 2026 · 4:03 PM EDT

Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024)

Zoetis (ZTS) posted quarterly Short-Term Debt issuances of -$24.0 million for Q2 2024, down 2300.0% year-over-year from $1.1 million in Q3 2023, and down 214.29% quarter-over-quarter from $21.0 million in Q1 2024.

Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024) Analysis & Trends

Zoetis (ZTS) has reported Short-Term Debt issuances for 12 consecutive years, with -$24.0 million the latest figure, recorded in Q2 2024.

  • In Q2 2024, Short-Term Debt issuances fell 2300.0% year-over-year to -$24.0 million; the TTM figure through Mar 2025 stood at -$24.0 million (down 214.29% YoY), while the FY2024 annual figure was -$3.0 million, down 400.0% from the prior year.
  • Short-Term Debt issuances eased to -$24.0 million in Q2 2024 per ZTS's latest filing, from $21.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $21.0 million in Q1 2024 and bottomed at -$24.0 million in Q2 2024.
  • Historically, Short-Term Debt issuances has averaged $0.0 across 5 years, with a median of $1.0 million in 2020.
  • On a YoY basis, Short-Term Debt issuances climbed as much as 2000.0% in 2024 and fell as far as 2300.0% in 2024.
  • Zoetis' Short-Term Debt issuances stood at $3.0 million in 2020, then slumped by 233.33% to -$4.0 million in 2021, then jumped by 75.0% to -$1.0 million in 2022, then surged by 200.0% to $1.0 million in 2023, then sank by 2500.0% to -$24.0 million in 2024.
  • Business Quant data shows ZTS's Short-Term Debt issuances at -$24.0 million in Q2 2024, $21.0 million in Q1 2024, and $1.0 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 50.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Alkermes 8.07 Bn 7.41 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 -24.00 Mn
Jun 30, 2024 -24.00 Mn
Mar 31, 2024 21.00 Mn
Mar 31, 2024 21.00 Mn
Dec 31, 2023 1.00 Mn
Dec 31, 2023 1.00 Mn
Jun 30, 2023 -1.00 Mn
Jun 30, 2023 -1.00 Mn
Mar 31, 2023 1.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 -1.00 Mn
Dec 31, 2022 -1.00 Mn
Sep 30, 2022 1.00 Mn
Sep 30, 2022 1.00 Mn
Jun 30, 2022 2.00 Mn
Jun 30, 2022 2.00 Mn
Sep 30, 2021 -4.00 Mn
Sep 30, 2021 -4.00 Mn
Dec 31, 2020 3.00 Mn
Dec 31, 2020 3.00 Mn